This is a table of type quadgram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
quadgram | frequency |
---|---|
severe acute respiratory syndrome | 17101 |
acute respiratory syndrome coronavirus | 8022 |
of severe acute respiratory | 5074 |
middle east respiratory syndrome | 3899 |
medrxiv a license to | 3841 |
a license to display | 3841 |
to display the preprint | 3841 |
granted medrxiv a license | 3841 |
license to display the | 3841 |
display the preprint in | 3840 |
who has granted medrxiv | 3831 |
has granted medrxiv a | 3831 |
is the author funder | 3610 |
copyright holder for this | 3524 |
the copyright holder for | 3505 |
the preprint in perpetuity | 3248 |
holder for this preprint | 2725 |
east respiratory syndrome coronavirus | 2580 |
acute respiratory distress syndrome | 2545 |
certified by peer review | 2396 |
not certified by peer | 2394 |
was not certified by | 2394 |
for this preprint this | 2291 |
preprint this version posted | 2291 |
this preprint this version | 2291 |
in patients with covid | 2282 |
which was not certified | 2256 |
the severe acute respiratory | 2020 |
for the treatment of | 1998 |
with severe acute respiratory | 1929 |
it is made available | 1888 |
made available under a | 1887 |
is made available under | 1887 |
international license it is | 1852 |
license it is made | 1852 |
a l p r | 1757 |
r n a l | 1755 |
o u r n | 1755 |
j o u r | 1755 |
u r n a | 1755 |
l p r e | 1753 |
r o o f | 1753 |
p r o o | 1753 |
n a l p | 1753 |
a is the author | 1640 |
under a is the | 1638 |
available under a is | 1638 |
in patients with severe | 1409 |
of patients infected with | 1389 |
in the united states | 1338 |
at the time of | 1307 |
in the context of | 1289 |
on the other hand | 1286 |
the world health organization | 1280 |
in the treatment of | 1279 |
in the absence of | 1278 |
disease control and prevention | 1241 |
for disease control and | 1190 |
as well as the | 1111 |
reuse allowed without permission | 1105 |
no reuse allowed without | 1105 |
in the case of | 1071 |
of a novel coronavirus | 1044 |
of hospitalized patients with | 1014 |
this article is protected | 1013 |
is protected by copyright | 1013 |
article is protected by | 1013 |
patients with coronavirus disease | 1010 |
systematic review and meta | 967 |
clinical features of patients | 960 |
patients with severe acute | 953 |
in the presence of | 952 |
of patients with covid | 948 |
infected with novel coronavirus | 929 |
the treatment of covid | 924 |
a systematic review and | 917 |
with novel coronavirus in | 908 |
features of patients infected | 904 |
patients infected with novel | 900 |
of middle east respiratory | 857 |
has been shown to | 847 |
novel coronavirus in wuhan | 837 |
it is important to | 835 |
a novel coronavirus from | 821 |
critically ill patients with | 813 |
this this version posted | 797 |
for this this version | 797 |
holder for this this | 797 |
for the detection of | 783 |
patients with novel coronavirus | 777 |
of the novel coronavirus | 774 |
respiratory syndrome coronavirus infection | 754 |
centers for disease control | 739 |
patients with severe covid | 734 |
acute respiratory syndrome in | 732 |
patients infected with sars | 715 |
hospitalized patients with covid | 705 |
a retrospective cohort study | 695 |
and clinical characteristics of | 687 |
from patients with pneumonia | 682 |
of coronavirus disease in | 679 |
as a result of | 635 |
with acute respiratory distress | 635 |
is one of the | 634 |
coronavirus disease in china | 630 |
novel coronavirus from patients | 629 |
of novel coronavirus pneumonia | 629 |
coronavirus from patients with | 628 |
patients with pneumonia in | 627 |
in addition to the | 625 |
on the basis of | 625 |
characteristics of coronavirus disease | 624 |
an important role in | 623 |
the spread of the | 622 |
was found to be | 621 |
with pneumonia in china | 621 |
by severe acute respiratory | 618 |
of the severe acute | 618 |
with a new coronavirus | 615 |
clinical characteristics of coronavirus | 614 |
of the spike protein | 602 |
associated with a new | 601 |
outbreak associated with a | 599 |
a new coronavirus of | 598 |
pneumonia outbreak associated with | 598 |
new coronavirus of probable | 597 |
of probable bat origin | 597 |
a pneumonia outbreak associated | 596 |
coronavirus of probable bat | 596 |
at the same time | 586 |
of the sars coronavirus | 581 |
for the development of | 574 |
for severe acute respiratory | 573 |
r i p t | 572 |
c r i p | 572 |
s c r i | 572 |
m a n u | 570 |
n u s c | 570 |
a n u s | 570 |
u s c r | 570 |
characteristics of cases of | 564 |
hospitalized patients with novel | 560 |
center for disease control | 550 |
one of the most | 547 |
clinical characteristics of cases | 536 |
epidemiological and clinical characteristics | 534 |
a large number of | 534 |
depends on ace and | 532 |
on ace and tmprss | 531 |
and is blocked by | 531 |
is blocked by a | 530 |
blocked by a clinically | 529 |
cell entry depends on | 529 |
in patients with sars | 528 |
entry depends on ace | 528 |
ace and tmprss and | 528 |
associated with severe acute | 525 |
this version posted may | 523 |
by a clinically proven | 523 |
and tmprss and is | 522 |
a clinically proven protease | 522 |
tmprss and is blocked | 521 |
in severe acute respiratory | 519 |
at the end of | 519 |
clinically proven protease inhibitor | 519 |
were found to be | 517 |
the authors declare that | 515 |
clinical characteristics of hospitalized | 514 |
after the onset of | 511 |
and risk factors for | 511 |
characteristics of hospitalized patients | 509 |
of critically ill patients | 508 |
this version posted september | 503 |
preprint the copyright holder | 502 |
novel coronavirus pneumonia in | 501 |
in vitro and in | 494 |
cases of novel coronavirus | 493 |
have been shown to | 491 |
the onset of symptoms | 488 |
of the s protein | 487 |
the middle east respiratory | 478 |
this version posted august | 477 |
novel coronavirus associated with | 475 |
the total number of | 475 |
a novel coronavirus associated | 474 |
the spike protein of | 473 |
of cases of novel | 471 |
c e p t | 470 |
and middle east respiratory | 470 |
p t e d | 469 |
c c e p | 469 |
e p t e | 469 |
no conflict of interest | 468 |
with the novel coronavirus | 468 |
coronavirus pneumonia in wuhan | 467 |
a c c e | 467 |
associated with acute respiratory | 466 |
the end of the | 465 |
outbreak of severe acute | 464 |
coronavirus associated with severe | 463 |
risk factors for mortality | 460 |
a wide range of | 460 |
e d m a | 460 |
t e d m | 460 |
d m a n | 460 |
in the present study | 459 |
the detection of sars | 459 |
it is possible that | 458 |
this version posted june | 458 |
studies have shown that | 455 |
play a role in | 455 |
on the surface of | 447 |
a functional receptor for | 446 |
that they have no | 445 |
infected pneumonia in wuhan | 445 |
the course of the | 441 |
tested positive for sars | 441 |
the intensive care unit | 436 |
in the pathogenesis of | 431 |
been shown to be | 429 |
can be used to | 427 |
the authors declare no | 427 |
factors for mortality of | 421 |
to severe acute respiratory | 420 |
clinical course and risk | 419 |
for mortality of adult | 418 |
course and risk factors | 418 |
in hospitalized patients with | 417 |
vitro and in vivo | 416 |
in critically ill patients | 416 |
adult inpatients with covid | 415 |
the central nervous system | 415 |
in a patient with | 414 |
as shown in figure | 413 |
mortality of adult inpatients | 413 |
the presence of sars | 412 |
of adult inpatients with | 412 |
of patients with sars | 412 |
spread of the virus | 409 |
in the development of | 406 |
respiratory syndrome coronavirus spike | 406 |
respiratory syndrome coronavirus in | 404 |
identification of a novel | 404 |
spike protein of sars | 401 |
by the world health | 399 |
declare that they have | 397 |
chinese center for disease | 397 |
cd and cd t | 396 |
in the setting of | 395 |
epidemiology of novel coronavirus | 394 |
is a functional receptor | 391 |
the beginning of the | 389 |
authors declare that they | 385 |
detection of novel coronavirus | 385 |
and epidemiology of novel | 384 |
a report of cases | 383 |
functional receptor for the | 382 |
a novel coronavirus in | 382 |
this version posted july | 381 |
virus origins and receptor | 380 |
for virus origins and | 379 |
coronavirus in patients with | 379 |
origins and receptor binding | 379 |
implications for virus origins | 378 |
in patients with coronavirus | 374 |
food and drug administration | 373 |
of the immune system | 371 |
chronic obstructive pulmonary disease | 370 |
syndrome in hong kong | 368 |
respiratory syndrome in hong | 368 |
was approved by the | 367 |
structure of the sars | 366 |
the severity of the | 365 |
em structure of the | 361 |
in vero e cells | 357 |
efficacy and safety of | 356 |
characterisation and epidemiology of | 355 |
to be associated with | 355 |
genomic characterisation and epidemiology | 354 |
the treatment of sars | 354 |
transmission dynamics in wuhan | 353 |
in the general population | 353 |
the chinese center for | 352 |
during the course of | 352 |
in the number of | 351 |
diagnosis and treatment of | 347 |
associated with the novel | 346 |
for the management of | 345 |
a systematic review of | 345 |
an increased risk of | 341 |
caused by severe acute | 339 |
of the virus in | 338 |
has been reported to | 336 |
the s protein of | 335 |
increase the risk of | 335 |
on the use of | 334 |
human respiratory disease in | 334 |
early transmission dynamics in | 334 |
of novel coronavirus in | 332 |
it has been shown | 331 |
infection prevention and control | 331 |
antibody responses to sars | 331 |
associated with human respiratory | 330 |
new coronavirus associated with | 329 |
a new coronavirus associated | 329 |
with human respiratory disease | 329 |
coronavirus associated with human | 329 |
a familial cluster of | 328 |
the presence of the | 328 |
cause of severe acute | 327 |
respiratory disease in china | 326 |
as well as in | 326 |
syndrome coronavirus spike protein | 325 |
receptor for the sars | 321 |
the novel coronavirus indicating | 320 |
in the management of | 319 |
ill patients with covid | 318 |
and cd t cells | 318 |
were more likely to | 316 |
it has been reported | 315 |
as shown in fig | 315 |
play an important role | 314 |
in the respiratory tract | 314 |
in the prefusion conformation | 312 |
novel coronavirus in patients | 309 |
in accordance with the | 307 |
important lessons from the | 307 |
have been reported in | 304 |
and important lessons from | 304 |
a study of a | 303 |
of and important lessons | 303 |
it is likely that | 303 |
reduce the risk of | 302 |
characteristics of and important | 302 |
the spread of sars | 301 |
the rest of the | 300 |
of pneumonia associated with | 300 |
from the coronavirus disease | 299 |
of a family cluster | 299 |
the upper respiratory tract | 297 |
in the form of | 297 |
it should be noted | 297 |
familial cluster of pneumonia | 297 |
the results of the | 296 |
lessons from the coronavirus | 296 |
of personal protective equipment | 295 |
pneumonia associated with the | 295 |
spike in the prefusion | 294 |
the receptor binding domain | 294 |
during the sars outbreak | 294 |
cluster of pneumonia associated | 294 |
a risk factor for | 293 |
functional receptor for sars | 293 |
antigenicity of the sars | 292 |
study of a family | 292 |
studies are needed to | 292 |
are more likely to | 292 |
of angiotensin converting enzyme | 291 |
ncov spike in the | 291 |
from the chinese center | 289 |
of patients with severe | 289 |
the active site of | 289 |
a role in the | 289 |
similar to that of | 288 |
this version posted october | 288 |
and antigenicity of the | 287 |
for the sars coronavirus | 287 |
the crystal structure of | 286 |
for the diagnosis of | 285 |
treatment of severe acute | 285 |
isolation and characterization of | 285 |
it is necessary to | 284 |
the role of the | 283 |
the presence of a | 283 |
the treatment of severe | 282 |
at the beginning of | 282 |
born to mothers with | 281 |
cases from the chinese | 281 |
enzyme is a functional | 280 |
would like to thank | 279 |
novel coronavirus indicating person | 279 |
summary of a report | 279 |
used in this study | 279 |
of a report of | 278 |
characteristics and outcomes of | 278 |
study was approved by | 278 |
the number of cases | 278 |
s protein of sars | 277 |
the centers for disease | 277 |
we found that the | 276 |
no conflicts of interest | 276 |
to the development of | 276 |
of the coronavirus disease | 276 |
outcomes of critically ill | 275 |
in the course of | 274 |
the recently emerged novel | 274 |
case of novel coronavirus | 274 |
has been reported that | 273 |
recently emerged novel coronavirus | 273 |
and chloroquine effectively inhibit | 273 |
chloroquine effectively inhibit the | 273 |
of the virus and | 273 |
effectively inhibit the recently | 273 |
remdesivir and chloroquine effectively | 273 |
inhibit the recently emerged | 273 |
the early stage of | 272 |
should be noted that | 272 |
and the number of | 271 |
may be due to | 271 |
by the severe acute | 271 |
an observational cohort study | 271 |
and outcomes of critically | 270 |
we would like to | 269 |
the impact of the | 268 |
plays an important role | 267 |
with the use of | 266 |
the early stages of | 266 |
prevention and control of | 266 |
by the novel coronavirus | 265 |
a higher risk of | 265 |
report of cases from | 265 |
jurisdictional claims in published | 264 |
has been reported in | 264 |
the structure of the | 264 |
regard to jurisdictional claims | 264 |
remains neutral with regard | 264 |
with regard to jurisdictional | 264 |
neutral with regard to | 264 |
in published maps and | 264 |
to jurisdictional claims in | 264 |
maps and institutional affiliations | 264 |
claims in published maps | 264 |
published maps and institutional | 264 |
for the presence of | 263 |
nature remains neutral with | 263 |
a key role in | 263 |
the incubation period of | 263 |
a public health emergency | 263 |
the diagnosis of covid | 263 |
springer nature remains neutral | 263 |
influenza a h n | 262 |
in the lungs of | 260 |
of cases from the | 260 |
the development of a | 259 |
novel coronavirus in the | 258 |
converting enzyme is a | 257 |
for the first time | 257 |
has been shown that | 256 |
the spread of covid | 256 |
with respect to the | 256 |
the lower respiratory tract | 255 |
which was not peer | 255 |
transcription polymerase chain reaction | 255 |
as well as a | 255 |
the context of the | 255 |
respiratory distress syndrome and | 254 |
has been associated with | 253 |
is likely to be | 253 |
the pathogenesis of sars | 253 |
the functional receptor for | 252 |
more likely to be | 252 |
are shown in table | 252 |
course of the disease | 251 |
the severity of covid | 251 |
days after symptom onset | 251 |
the first case of | 250 |
risk factors associated with | 250 |
pathological findings of covid | 250 |
outcomes of patients with | 249 |
the early phase of | 249 |
first case of novel | 248 |
the expression of ace | 248 |
have been associated with | 247 |
in patients infected with | 247 |
ill patients with sars | 247 |
this work was supported | 247 |
this is the first | 246 |
note springer nature remains | 246 |
important to note that | 246 |
it was found that | 246 |
as compared with sars | 246 |
aerosol and surface stability | 245 |
committee on taxonomy of | 243 |
the majority of the | 243 |
and surface stability of | 243 |
can be found in | 242 |
the fact that the | 242 |
international committee on taxonomy | 242 |
with novel coronavirus pneumonia | 241 |
the surface of the | 240 |
be used as a | 240 |
is important to note | 240 |
the risk of infection | 240 |
clinical course and outcomes | 239 |
the use of a | 238 |
course and outcomes of | 238 |
receptor for sars coronavirus | 236 |
a review of the | 235 |
the causative agent of | 235 |
surface stability of sars | 235 |
health emergency of international | 234 |
of the immune response | 234 |
the novel coronavirus from | 233 |
transmission of the virus | 233 |
were included in the | 233 |
caused by a novel | 232 |
days after the onset | 232 |
and severe acute respiratory | 232 |
of the virus to | 232 |
this version posted april | 232 |
have been reported to | 232 |
outbreak of novel coronavirus | 231 |
higher than that of | 231 |
the time of the | 230 |
virological assessment of hospitalized | 230 |
a first step in | 230 |
national health commission of | 230 |
important role in the | 230 |
work was supported by | 230 |
there is no evidence | 229 |
prevention and treatment of | 229 |
tissue distribution of ace | 228 |
public health emergency of | 227 |
coronavirus in the united | 226 |
with middle east respiratory | 226 |
entry into host cells | 226 |
the novel coronavirus disease | 225 |
have the potential to | 225 |
the context of covid | 225 |
the efficacy and safety | 225 |
to the ace receptor | 224 |
first step in understanding | 224 |
are summarized in table | 223 |
declare no conflict of | 223 |
mortality in patients with | 223 |
emergency of international concern | 223 |
treatment of patients with | 223 |
as severe acute respiratory | 223 |
and approved the final | 223 |
a total of patients | 223 |
structural basis for the | 223 |
may play a role | 222 |
is based on the | 222 |
with the exception of | 222 |
in response to the | 222 |
the innate immune response | 222 |
distribution of ace protein | 221 |
in understanding sars pathogenesis | 221 |
the international committee on | 221 |
these results suggest that | 221 |
step in understanding sars | 221 |
to the lack of | 220 |
this version posted november | 220 |
multisystem inflammatory syndrome in | 220 |
was supported by the | 220 |
in upper respiratory specimens | 220 |
for patients with covid | 220 |
specimens of infected patients | 218 |
of the viral genome | 218 |
severity of the disease | 217 |
the virus in the | 217 |
in the spike protein | 217 |
the innate immune system | 217 |
inflammatory syndrome in children | 216 |
authors declare no conflict | 216 |
characterization of a novel | 216 |
is consistent with the | 216 |
assessment of hospitalized patients | 215 |
viral load in upper | 215 |
upper respiratory specimens of | 214 |
load in upper respiratory | 214 |
all over the world | 213 |
in adults hospitalized with | 213 |
on taxonomy of viruses | 213 |
respiratory specimens of infected | 213 |
review of the literature | 213 |
with a history of | 213 |
is associated with a | 212 |
as shown in table | 212 |
a better understanding of | 212 |
cytokine storm syndromes and | 211 |
consider cytokine storm syndromes | 211 |
the outbreak of sars | 211 |
of convalescent plasma therapy | 211 |
a randomized clinical trial | 210 |
a possible cause of | 210 |
of viral rna in | 210 |
human immunodeficiency virus type | 209 |
has the potential to | 209 |
the sars outbreak in | 209 |
as part of the | 209 |
transmission of severe acute | 209 |
as a possible cause | 209 |
storm syndromes and immunosuppression | 209 |
spread of the disease | 208 |
by a novel coronavirus | 208 |
there was no significant | 207 |
it is known that | 207 |
death in patients with | 207 |
in different types of | 207 |
are likely to be | 207 |
been reported to be | 207 |
the diagnosis and treatment | 206 |
species severe acute respiratory | 206 |
hospitalized with severe covid | 206 |
and the risk of | 206 |
the immune response to | 206 |
to the intensive care | 206 |
may be related to | 206 |
peripheral blood mononuclear cells | 205 |
declare no competing interests | 205 |
be due to the | 205 |
adults hospitalized with severe | 205 |
as a treatment of | 204 |
of novel coronavirus disease | 203 |
during the study period | 203 |
the species severe acute | 203 |
the case of sars | 203 |
hydroxychloroquine and azithromycin as | 202 |
preprint in the copyright | 202 |
authors declare no competing | 202 |
in the copyright holder | 202 |
a member of the | 202 |
be related to the | 202 |
study clinical characteristics of | 202 |
the preprint in the | 202 |
it is difficult to | 201 |
and azithromycin as a | 201 |
ncov and naming it | 201 |
the treatment of patients | 201 |
of the disease and | 201 |
a treatment of covid | 201 |
was performed using the | 201 |
the limit of detection | 201 |
the time of writing | 200 |
clinical characteristics of patients | 200 |
possible cause of severe | 200 |
and naming it sars | 200 |
crystal structure of sars | 199 |
innate and adaptive immune | 199 |
coronavirus as a possible | 199 |
azithromycin as a treatment | 199 |
the basis of the | 199 |
the use of the | 199 |
of this study was | 199 |
reverse transcription polymerase chain | 198 |
between the two groups | 198 |
there is an urgent | 198 |
that the use of | 198 |
can be used for | 197 |
was added to the | 197 |
sensitivity and specificity of | 196 |
and clinical features of | 196 |
can be used as | 196 |
is responsible for the | 196 |
management of patients with | 195 |
to reduce the risk | 195 |
in the intensive care | 195 |
a critical role in | 194 |
and treatment of covid | 193 |
to the presence of | 193 |
the spike glycoprotein of | 193 |
a crucial role in | 193 |
it is possible to | 193 |
to better understand the | 192 |
patients with severe disease | 192 |
for the novel coronavirus | 192 |
different types of clinical | 191 |
results of an open | 190 |
and viral load in | 190 |
an analysis based on | 190 |
in contrast to the | 190 |
at room temperature for | 190 |
structural studies of sars | 190 |
into the host cell | 189 |
types of clinical specimens | 189 |
is an urgent need | 189 |
of acute respiratory distress | 189 |
for the prevention and | 189 |
for the recognition of | 189 |
as one of the | 189 |
acute respiratory syndrome a | 189 |
transcriptase polymerase chain reaction | 188 |
and the use of | 188 |
novel coronavirus from wuhan | 188 |
has not yet been | 188 |
we were able to | 188 |
a trial of lopinavir | 188 |
in the early stage | 187 |
crystal structure of the | 187 |
the onset of the | 187 |
for the prevention of | 186 |
in new york city | 186 |
viral load in a | 186 |
the creative commons attribution | 186 |
severe cases of covid | 186 |
and the presence of | 186 |
it has been suggested | 185 |
due to the lack | 185 |
a small number of | 184 |
inflammatory cytokines and chemokines | 184 |
by the end of | 184 |
the aim of this | 184 |
to the fact that | 184 |
is thought to be | 184 |
the sensitivity of the | 183 |
patients hospitalized with covid | 183 |
to the use of | 183 |
for detection of sars | 183 |
the outbreak of covid | 183 |
may be associated with | 183 |
the vast majority of | 183 |
ritonavir in adults hospitalized | 183 |
immune response to sars | 182 |
with suspected or confirmed | 182 |
and shortness of breath | 182 |
was used as a | 182 |
novel coronavirus from a | 181 |
analysis based on decade | 181 |
spike glycoprotein of sars | 181 |
was associated with a | 181 |
long structural studies of | 180 |
in vitro antiviral activity | 180 |
manifestations of hospitalized patients | 180 |
clinical characteristics of covid | 180 |
safety and efficacy of | 180 |
patients with acute respiratory | 179 |
the transmission of sars | 179 |
isolation of a novel | 179 |
human airway epithelial cells | 178 |
progression and viral load | 178 |
from a man with | 178 |
acute respiratory syndrome the | 178 |
of the creative commons | 178 |
for treatment of covid | 178 |
in the current study | 178 |
the absence of a | 178 |
pneumonia in saudi arabia | 178 |
with pneumonia in saudi | 178 |
clinical progression and viral | 178 |
in a community outbreak | 178 |
response in patients with | 178 |
an increase in the | 177 |
distributed under the terms | 177 |
a man with pneumonia | 177 |
a descriptive study clinical | 177 |
prevent the spread of | 177 |
a result of the | 177 |
man with pneumonia in | 177 |
as the number of | 177 |
national institutes of health | 176 |
entry into the host | 176 |
of the innate immune | 176 |
a community outbreak of | 176 |
china clinical characteristics of | 176 |
igm and igg antibodies | 176 |
coronavirus from a man | 176 |
the activation of the | 176 |
for critically ill patients | 175 |
from a patient with | 175 |
was shown to be | 175 |
to that of the | 175 |
the epidemiological characteristics of | 175 |
and outcomes of patients | 175 |
of the sars epidemic | 175 |
novel severe acute respiratory | 175 |
the risk of sars | 174 |
in the early phase | 174 |
origin and evolution of | 174 |
basis for design of | 174 |
a major outbreak of | 174 |
a wide variety of | 174 |
expression of ace in | 174 |
load in a community | 174 |
in the face of | 173 |
to acute respiratory distress | 173 |
to be able to | 173 |
for the use of | 173 |
the clinical characteristics of | 173 |
porcine epidemic diarrhea virus | 173 |
of viral load in | 173 |
in the regulation of | 173 |
as compared to the | 173 |
has been found to | 173 |
the s protein is | 172 |
mechanism of action of | 172 |
related to the sars | 172 |
is mediated by the | 172 |
the genome sequence of | 172 |
orf a and orf | 172 |
and personal protective equipment | 171 |
basis for the recognition | 171 |
for patients with severe | 171 |
the protein data bank | 171 |
that there is a | 171 |
as well as to | 171 |
our understanding of the | 171 |
a patient with covid | 171 |
early phase of the | 170 |
and the development of | 170 |
novel coronavirus infection in | 170 |
the pathogenesis of covid | 170 |
characteristics of novel coronavirus | 170 |
the binding of the | 170 |
by the fact that | 169 |
have no conflict of | 169 |
has been suggested that | 169 |
in the majority of | 169 |
is shown in figure | 168 |
in a cohort of | 168 |
was detected in the | 168 |
was obtained from the | 168 |
in the upper respiratory | 168 |
infection from an asymptomatic | 168 |
for middle east respiratory | 167 |
the most common symptoms | 167 |
these data suggest that | 167 |
at the s s | 167 |
article distributed under the | 167 |
not included in the | 167 |
be one of the | 167 |
binding domain complexed with | 167 |
of an outbreak of | 166 |
of the number of | 166 |
use of personal protective | 166 |
for the diagnosis and | 166 |
the first week of | 166 |
after onset of symptoms | 166 |
neonates born to mothers | 165 |
to the sars coronavirus | 165 |
pregnant women with covid | 165 |
treatment of novel coronavirus | 165 |
in view of the | 165 |
the basic reproduction number | 165 |
as a consequence of | 165 |
this study was to | 165 |
a randomized controlled trial | 164 |
with coronavirus disease in | 164 |
distress syndrome and death | 164 |
the risk of transmission | 164 |
by the presence of | 164 |
it was reported that | 163 |
upper and lower respiratory | 163 |
of a patient with | 163 |
it has also been | 163 |
the expression of the | 163 |
the sars coronavirus spike | 163 |
the absence of any | 163 |
major outbreak of severe | 163 |
hospitalized patients with coronavirus | 162 |
number of confirmed cases | 162 |
in this study were | 162 |
to the best of | 162 |
detection of severe acute | 162 |
in acute respiratory distress | 162 |
the viral spike protein | 162 |
the antiviral activity of | 162 |
the size of the | 162 |
in the early stages | 162 |
respiratory syndrome coronavirus and | 161 |
in the range of | 161 |
disease prevention and control | 161 |
the results showed that | 161 |
a broad range of | 161 |
the rapid spread of | 161 |
the majority of patients | 161 |
more likely to have | 161 |
treatment of severe covid | 161 |
potential conflict of interest | 161 |
access article distributed under | 161 |
the prevention and treatment | 160 |
alone or in combination | 160 |
of mouse hepatitis virus | 160 |
the use of corticosteroids | 160 |
caused by the novel | 160 |
for each of the | 159 |
have no competing interests | 159 |
cases of severe acute | 159 |
the sars epidemic in | 159 |
as a function of | 159 |
best of our knowledge | 159 |
they have no competing | 159 |
and death in patients | 159 |
factors associated with acute | 159 |
the best of our | 158 |
used for the treatment | 158 |
from an asymptomatic contact | 158 |
the national health commission | 158 |
informed consent was obtained | 158 |
isolated from a patient | 158 |
management of severe acute | 158 |
in a mouse model | 158 |
of the novel human | 157 |
the number of patients | 157 |
asymptomatic contact in germany | 157 |
an asymptomatic contact in | 157 |
prognosis in patients with | 157 |
that there is no | 157 |
of the sars outbreak | 157 |
has also been reported | 157 |
of patients with coronavirus | 157 |
no significant difference in | 157 |
little is known about | 157 |
the diamond princess cruise | 157 |
the stability of the | 157 |
are shown in figure | 156 |
in terms of the | 156 |
the ability of the | 156 |
s and s subunits | 156 |
it was shown that | 156 |
the epithelial cells of | 156 |
syndrome and death in | 155 |
outcomes in patients with | 155 |
ncov infection from an | 155 |
analyses were performed using | 155 |
to prevent the spread | 155 |
is known to be | 155 |
the s and s | 155 |
a potent inhibitor of | 155 |
rna was detected in | 155 |
were obtained from the | 154 |
the nucleocapsid protein of | 154 |
health commission of the | 154 |
diamond princess cruise ship | 154 |
of coronavirus spike proteins | 154 |
the novel coronavirus sars | 154 |
the replication of sars | 154 |
been found to be | 154 |
to the host cell | 154 |
the d g mutation | 154 |
at increased risk for | 153 |
h n influenza virus | 153 |
the acute phase of | 153 |
protein of severe acute | 153 |
of cd t cells | 153 |
a high level of | 152 |
a case series of | 152 |
of the patients with | 152 |
of sars and mers | 152 |
binding domain of the | 152 |
sequence of the sars | 152 |
admitted to the hospital | 152 |
and lower respiratory tract | 152 |
viral load in the | 152 |
to be involved in | 152 |
it is worth noting | 152 |
at increased risk of | 152 |
and acute respiratory distress | 152 |
the proximal origin of | 152 |
of ace and tmprss | 151 |
have shown that the | 151 |
community outbreak of coronavirus | 151 |
against severe acute respiratory | 151 |
respiratory distress syndrome in | 151 |
and evolution of pathogenic | 151 |
caused by the severe | 151 |
better understanding of the | 151 |
evolution of pathogenic coronaviruses | 151 |
the evolution of the | 150 |
the case of the | 150 |
a retrospective review of | 150 |
the clinical course of | 150 |
early stages of the | 150 |
on the day of | 150 |
or in combination with | 150 |
proximal origin of sars | 150 |
the impact of covid | 149 |
in the event of | 149 |
consent was obtained from | 149 |
associated with an increased | 149 |
in the middle east | 148 |
associated with poor prognosis | 148 |
has been detected in | 148 |
parts of the world | 148 |
the start of the | 148 |
acute respiratory syndrome and | 148 |
authors would like to | 148 |
in the united kingdom | 148 |
may contribute to the | 147 |
in the control group | 147 |
severe acute respiratory infection | 147 |
of sars coronavirus spike | 147 |
it is noteworthy that | 147 |
the nature of the | 147 |
pp a and pp | 147 |
over the course of | 147 |
the diagnosis of sars | 147 |
as well as other | 146 |
patients with middle east | 146 |
posterior oropharyngeal saliva samples | 146 |
confirmed cases of covid | 146 |
to the severity of | 146 |
in a variety of | 146 |
of novel coronavirus infection | 146 |
than that of the | 146 |
angiotensin ii receptor blockers | 146 |
during the incubation period | 145 |
presence or absence of | 145 |
rna dependent rna polymerase | 145 |
accepted article this article | 145 |
these findings suggest that | 145 |
and characterization of a | 145 |
the effect of the | 145 |
article this article is | 145 |
days after onset of | 145 |
immune response in patients | 145 |
in balb c mice | 145 |
and serum antibody responses | 145 |
carrier transmission of covid | 144 |
asymptomatic carrier transmission of | 144 |
in the field of | 144 |
viral load in posterior | 144 |
read and approved the | 144 |
the ministry of health | 144 |
convalescent plasma therapy in | 143 |
in treatment of covid | 143 |
load in posterior oropharyngeal | 143 |
in posterior oropharyngeal saliva | 143 |
similar to those of | 143 |
was used for the | 143 |
reverse transcriptase polymerase chain | 143 |
for disease prevention and | 143 |
the sensitivity and specificity | 143 |
at high risk of | 142 |
the potential risk of | 142 |
in human airway epithelial | 142 |
to be the most | 142 |
from patients with covid | 142 |
were positive for sars | 142 |
a crucial role of | 142 |
has been identified as | 142 |
as soon as possible | 142 |
have been found to | 142 |
the presence of viral | 142 |
analysis of the sars | 142 |
were infected with sars | 142 |
of viruses related to | 141 |
were admitted to the | 141 |
to that of sars | 141 |
the emergence of sars | 141 |
had a history of | 141 |
coronavirus isolated from a | 141 |
was observed in the | 141 |
approved the final manuscript | 141 |
antibody responses during infection | 141 |
the interaction between the | 141 |
to mothers with covid | 141 |
receptor recognition by the | 141 |
was not associated with | 141 |
animals in southern china | 141 |
at higher risk of | 141 |
profiles of viral load | 141 |
responses during infection by | 140 |
serum antibody responses during | 140 |
studies of sars coronavirus | 140 |
of hepatitis c virus | 140 |
is worth noting that | 140 |
are included in the | 140 |
could be used to | 140 |
temporal profiles of viral | 140 |
oropharyngeal saliva samples and | 140 |
high expression of ace | 140 |
samples and serum antibody | 140 |
during infection by sars | 140 |
of the international committee | 140 |
it is clear that | 140 |
from animals in southern | 140 |
saliva samples and serum | 140 |
recognition by the novel | 140 |
recent insights into emerging | 140 |
was defined as the | 140 |
have also been reported | 140 |
to the emergency department | 140 |
one of the main | 140 |
sars coronavirus from animals | 139 |
were observed in the | 139 |
role of angiotensin converting | 139 |
insights into emerging coronaviruses | 139 |
in patients with novel | 139 |
a case report of | 139 |
coronavirus from animals in | 139 |
viruses related to the | 139 |
of sars coronavirus infection | 139 |
during the sars epidemic | 139 |
an urgent need for | 139 |
a major role in | 139 |
cd t cell responses | 139 |
of the patients were | 139 |
and characterization of viruses | 138 |
be explained by the | 138 |
presumed asymptomatic carrier transmission | 138 |
can be detected in | 138 |
in relation to the | 138 |
this study was approved | 138 |
in the human population | 138 |
the sars coronavirus from | 138 |
the presence or absence | 138 |
the performance of the | 138 |
is supported by the | 137 |
disease in china clinical | 137 |
genome sequence of the | 137 |
studies are required to | 137 |
systematic review of the | 137 |
of the ace receptor | 137 |
further studies are needed | 137 |
the median age of | 137 |
was no significant difference | 137 |
characterization of viruses related | 137 |
in the active site | 136 |
of human immunodeficiency virus | 136 |
crucial role of angiotensin | 136 |
were found to have | 136 |
be involved in the | 136 |
included in the study | 136 |
included in this study | 136 |
which is consistent with | 136 |
endothelial cell infection and | 136 |
analysis was performed using | 136 |
t cell responses to | 136 |
the purpose of this | 135 |
the greater toronto area | 135 |
cd t cells in | 135 |
also been shown to | 135 |
a and pp ab | 135 |
epithelial cells of the | 135 |
the duration of the | 135 |
neurologic manifestations of hospitalized | 135 |
the number of infected | 135 |
early stage of the | 134 |
the neuroinvasive potential of | 134 |
in light of the | 134 |
admitted to the icu | 134 |
the host immune response | 134 |
clinical management of severe | 134 |
are listed in table | 134 |
a novel coronavirus outbreak | 134 |
was used as the | 133 |
patients with confirmed covid | 133 |
identification of severe acute | 133 |
in patients with acute | 133 |
of the n protein | 133 |
patients admitted to the | 133 |
with severe coronavirus disease | 133 |
play a key role | 133 |
for the study of | 133 |
of the new coronavirus | 133 |
the authors would like | 133 |
novel coronavirus outbreak of | 133 |
have been used to | 133 |
in a recent study | 133 |
written informed consent was | 133 |
of influenza a virus | 133 |
be considered as a | 133 |
the media briefing on | 132 |
before the onset of | 132 |
of the spike glycoprotein | 132 |
in combination with other | 132 |
in a study of | 132 |
remarks at the media | 132 |
the disease caused by | 132 |
a severe acute respiratory | 132 |
at the media briefing | 132 |
from severe acute respiratory | 132 |
of lopinavir ritonavir in | 132 |
is associated with the | 132 |
the case of a | 132 |
a final concentration of | 132 |
has also been shown | 132 |
is shown in fig | 132 |
outbreak of global health | 131 |
of the middle east | 131 |
risk of transmission of | 131 |
in the fight against | 131 |
on the cell surface | 131 |
review of medical records | 131 |
suspected or confirmed covid | 131 |
the mechanism of action | 131 |
risk factors for severe | 130 |
bound to the ace | 130 |
in the near future | 130 |
has been observed in | 130 |
of the respiratory tract | 130 |
an outbreak of novel | 130 |
on the one hand | 130 |
who tested positive for | 130 |
in line with the | 130 |
that can be used | 130 |
domain of the spike | 130 |
the peak of the | 130 |
they have no conflict | 130 |
mortality due to covid | 130 |
at the university of | 129 |
retrospective review of medical | 129 |
cells were infected with | 129 |
characteristics of an outbreak | 129 |
it has been demonstrated | 129 |
use of convalescent plasma | 129 |
the analysis of the | 129 |
in the peripheral blood | 129 |
due to the high | 129 |
in the process of | 129 |
coronavirus outbreak of global | 129 |
of global health concern | 129 |
of ace in the | 129 |
acute respiratory syndrome virus | 128 |
available under a author | 128 |
epidemiological characteristics of an | 128 |
shown in figure a | 128 |
infection and endotheliitis in | 128 |
the united states and | 128 |
are involved in the | 128 |
and endotheliitis in covid | 128 |
and angiotensin ii receptor | 128 |
the results of this | 128 |
the new york city | 128 |
under a author funder | 128 |
there is currently no | 128 |
be taken into account | 128 |
is considered to be | 128 |
cell infection and endotheliitis | 128 |
of sars coronavirus in | 128 |
the recognition of sars | 127 |
time polymerase chain reaction | 127 |
increase in the number | 127 |
in the new york | 127 |
white blood cell count | 127 |
the coronavirus study group | 127 |
expression of ace and | 127 |
as much as possible | 127 |
in most of the | 127 |
in the production of | 127 |
domain bound to the | 127 |
the prevention and control | 126 |
in the s protein | 126 |
in the greater toronto | 126 |
mediated by the viral | 126 |
the viral life cycle | 126 |
an intensive care unit | 126 |
european centre for disease | 126 |
in close contact with | 126 |
with an increased risk | 126 |
there is a need | 126 |
one of the major | 126 |
the potential role of | 125 |
hydroxychloroquine for the treatment | 125 |
control the spread of | 125 |
poor prognosis in patients | 125 |
the novel coronavirus outbreak | 125 |
are associated with poor | 125 |
the risk of covid | 125 |
neuroinvasive potential of sars | 125 |
in the formation of | 125 |
cases of coronavirus disease | 125 |
will need to be | 124 |
among health care workers | 124 |
with poor prognosis in | 124 |
severe acute respiratory distress | 124 |
on the role of | 124 |
the case fatality rate | 124 |
that the majority of | 124 |
patients infected with the | 124 |
is known about the | 124 |
were tested for sars | 124 |
lower than that of | 124 |
a and orf b | 124 |
a prospective cohort study | 124 |
global initiative on sharing | 124 |
was first reported in | 123 |
samples from patients with | 123 |
since the beginning of | 123 |
and its impact on | 123 |
of the viral rna | 123 |
of spike glycoprotein of | 123 |
at a concentration of | 123 |
a cluster of cases | 123 |
that the number of | 123 |
patients with sars in | 123 |
of novel coronavirus diseases | 123 |
caused by the sars | 123 |
the study was approved | 122 |
approved by the institutional | 122 |
structure of sars coronavirus | 122 |
the management of covid | 122 |
it is essential to | 122 |
vertical transmission potential of | 122 |
and the cardiovascular system | 122 |
min at room temperature | 122 |
upper respiratory tract infection | 122 |
of this study is | 122 |
epub ahead of print | 122 |
the lancet infectious diseases | 122 |
clinical characteristics of novel | 122 |
the extent to which | 122 |
sars coronavirus nucleocapsid protein | 122 |
centre for disease prevention | 122 |
binding domain bound to | 122 |
authors have declared that | 122 |
incidence of thrombotic complications | 122 |
the specificity of the | 122 |
icu patients with covid | 121 |
initiative on sharing all | 121 |
induced acute lung injury | 121 |
for up to days | 121 |
on sharing all influenza | 121 |
is caused by a | 121 |
the s subunit of | 121 |
has been used to | 121 |
it is not clear | 121 |
signs and symptoms of | 121 |
stages of the disease | 121 |
an update on the | 121 |
cytokines and chemokines in | 121 |
composition and divergence of | 121 |
as well as for | 121 |
is involved in the | 120 |
in nine pregnant women | 120 |
a high risk of | 120 |
sharing all influenza data | 120 |
lopinavir ritonavir in the | 120 |
cases have been reported | 120 |
tested negative for sars | 120 |
of pregnant women with | 120 |
in any of the | 120 |
in patients with mild | 120 |
intrauterine vertical transmission potential | 120 |
genomic characterization of the | 120 |
of thrombotic complications in | 120 |
first case of covid | 120 |
the ethics committee of | 120 |
could be due to | 120 |
the highest number of | 120 |
china clinical features of | 120 |
infants born to mothers | 119 |
syndrome associated with sars | 119 |
the origin of sars | 119 |
the binding affinity of | 119 |
an essential role in | 119 |
the quality of the | 119 |
vero e cells were | 119 |
a significant role in | 119 |
infection in nine pregnant | 119 |
the characteristics of the | 119 |
these results indicate that | 119 |
the viral load in | 119 |
the time of this | 119 |
transmission potential of covid | 119 |
of science and technology | 119 |
clinical features of covid | 119 |
to a lesser extent | 119 |
ritonavir in the treatment | 119 |
approved by the ethics | 119 |
and intrauterine vertical transmission | 118 |
statistical analyses were performed | 118 |
short period of time | 118 |
dosing design of hydroxychloroquine | 118 |
a high degree of | 118 |
is yet to be | 118 |
in an attempt to | 118 |
and the lack of | 118 |
be responsible for the | 118 |
characterization of the novel | 118 |
did not show any | 118 |
on the management of | 118 |
specific cd t cells | 118 |
mice transgenic for human | 118 |
vitro antiviral activity and | 118 |
during the coronavirus disease | 118 |
samples were collected from | 118 |
the first cases of | 118 |
the outbreak of the | 118 |
design of hydroxychloroquine for | 118 |
domain complexed with receptor | 118 |
of hydroxychloroquine for the | 118 |
clinical characteristics and intrauterine | 117 |
publicly reported confirmed cases | 117 |
there is evidence that | 117 |
by the addition of | 117 |
in the control of | 117 |
the virus and the | 117 |
to the number of | 117 |
and projection of optimized | 117 |
the formation of the | 117 |
is caused by the | 117 |
pathology of severe acute | 117 |
complications in critically ill | 117 |
activity and projection of | 117 |
is associated with decreased | 117 |
projection of optimized dosing | 117 |
and the pathogenesis of | 117 |
was identified as the | 117 |
antiviral activity and projection | 117 |
respiratory syndrome coronavirus replication | 117 |
characteristics and intrauterine vertical | 117 |
effectiveness of convalescent plasma | 117 |
due to lack of | 117 |
on an analysis of | 116 |
of immune response in | 116 |
abnormal coagulation parameters are | 116 |
to the world health | 116 |
were included in this | 116 |
in agreement with the | 116 |
at the level of | 116 |
optimized dosing design of | 116 |
the host cell membrane | 116 |
the context of a | 116 |
the interaction of the | 116 |
the number of confirmed | 116 |
and pathogenesis of coronaviruses | 116 |
respiratory syndrome coronavirus as | 116 |
of patients from wuhan | 116 |
it is reasonable to | 116 |
one of the first | 116 |
of optimized dosing design | 116 |
chloroquine phosphate has shown | 116 |
on virus entry and | 115 |
among patients with covid | 115 |
and the middle east | 115 |
virus entry and its | 115 |
host response to sars | 115 |
of the virus into | 115 |
in the city of | 115 |
patient with atypical pneumonia | 115 |
of the central nervous | 115 |
associated pneumonia in clinical | 115 |
the safety and efficacy | 115 |
pneumonia in clinical studies | 115 |
the activity of the | 115 |
based on an analysis | 115 |
diagnosis and management of | 115 |
of the most important | 115 |
cluster of cases of | 115 |
of the s subunit | 115 |
lower respiratory tract infections | 115 |
clinical predictors of mortality | 115 |
critically ill icu patients | 115 |
the transmission of the | 115 |
increases the risk of | 115 |
entry and its immune | 115 |
and other respiratory viruses | 115 |
and characteristics of patients | 115 |
been shown to have | 114 |
of the cytokine storm | 114 |
is due to the | 114 |
entry of the virus | 114 |
the declaration of helsinki | 114 |
the time of covid | 114 |
efficacy in treatment of | 114 |
phosphate has shown apparent | 114 |
epidemiological and clinical features | 114 |
are shown in fig | 114 |
that there are no | 114 |
dysregulation of immune response | 114 |
should be considered in | 114 |
is believed to be | 114 |
under the terms of | 114 |
parameters are associated with | 114 |
coronavirus spike protein by | 114 |
pandemic by the world | 114 |
has shown apparent efficacy | 114 |
by the ethics committee | 114 |
the city of wuhan | 114 |
shown apparent efficacy in | 114 |
with the severity of | 114 |
the origin of the | 114 |
and the role of | 114 |
coagulation parameters are associated | 114 |
a patient with atypical | 114 |
infectious diseases society of | 114 |
in intensive care units | 114 |
due to the presence | 114 |
pneumonia after visiting wuhan | 113 |
is possible that the | 113 |
the importance of the | 113 |
of the disease in | 113 |
this is an open | 113 |
was found to have | 113 |
the development of new | 113 |
an analysis of data | 113 |
sars coronavirus spike receptor | 113 |
characterization of spike glycoprotein | 113 |
of the patients had | 113 |
in critically ill icu | 113 |
have not yet been | 113 |
this is consistent with | 113 |
respiratory syndrome in canada | 113 |
the institutional review board | 113 |
type i and type | 113 |
group of the international | 113 |
study group of the | 113 |
with atypical pneumonia after | 113 |
atypical pneumonia after visiting | 113 |
apparent efficacy in treatment | 113 |
it is also important | 113 |
the terms of the | 113 |
for min at room | 113 |
with the help of | 113 |
acute lung injury and | 113 |
are presented in table | 113 |
the antiviral effects of | 113 |
was conducted in the | 112 |
disease caused by the | 112 |
were added to the | 112 |
an urgent need to | 112 |
university of hong kong | 112 |
sars coronavirus spike protein | 112 |
the management of patients | 112 |
it is believed that | 112 |
and adaptive immune responses | 112 |
the acute respiratory distress | 112 |
has been demonstrated that | 112 |
was added to each | 112 |
the development of vaccines | 112 |
as a risk factor | 112 |
terms of the creative | 112 |
the authors have no | 112 |
is the number of | 112 |
vertical transmission of sars | 111 |
during the outbreak of | 111 |
of mortality due to | 111 |
an overview of the | 111 |
when compared to the | 111 |
health care workers in | 111 |
have no conflicts of | 111 |
a mortality rate of | 111 |
at the onset of | 111 |
remains to be determined | 111 |
compassionate use of remdesivir | 111 |
with the development of | 111 |
the first days of | 111 |
hydroxychloroquine in patients with | 111 |
associated with disease severity | 111 |
is also important to | 111 |
acute respiratory syndrome identification | 111 |
the national institute of | 111 |
memory cd t cells | 111 |
diseases society of america | 111 |
thrombotic complications in critically | 111 |
are at higher risk | 111 |
is a potent inhibitor | 110 |
detection of viral rna | 110 |
in hong kong and | 110 |
was admitted to the | 110 |
with sars in the | 110 |
the immune system and | 110 |
of smell and taste | 110 |
in health and disease | 110 |
be used for the | 110 |
could be used as | 110 |
characteristics of patients infected | 110 |
it is interesting to | 110 |
study was supported by | 110 |
there has been a | 110 |
dependent rna polymerase from | 110 |
and its implications for | 110 |
respiratory syndrome identification of | 110 |
the emergence of a | 110 |
in the era of | 110 |
respiratory syndrome coronavirus a | 110 |
were found in the | 110 |
associated with a higher | 109 |
evidence for gastrointestinal infection | 109 |
by the use of | 109 |
the humoral immune response | 109 |
ill icu patients with | 109 |
are similar to those | 109 |
and tumor necrosis factor | 109 |
upper respiratory tract infections | 109 |
s s cleavage site | 109 |
a significant increase in | 109 |
used in the treatment | 109 |
of respiratory syncytial virus | 109 |
the development of the | 109 |
data of patients from | 109 |
and its immune cross | 109 |
respiratory syncytial virus infection | 109 |
viral entry into the | 109 |
it is unclear whether | 109 |
opening remarks at the | 109 |
can be seen in | 109 |
the pathogenesis of severe | 109 |
may be involved in | 109 |
for the identification of | 109 |
our results suggest that | 108 |
all authors contributed to | 108 |
to control the spread | 108 |
analysis of data of | 108 |
of cell entry and | 108 |
of pneumonia of unknown | 108 |
that most of the | 108 |
the impact of sars | 108 |
in the diagnosis of | 108 |
a limited number of | 108 |
be found in the | 108 |
functional assessment of cell | 107 |
a mouse model of | 107 |
assessment of cell entry | 107 |
on the number of | 107 |
of data of patients | 107 |
entry and receptor usage | 107 |
cells were transfected with | 107 |
and clinical course of | 107 |
safety and immunogenicity of | 107 |
in order to avoid | 107 |
h at room temperature | 107 |
and receptor usage for | 107 |
the upper and lower | 107 |
for gastrointestinal infection of | 107 |
close contact with a | 107 |
from publicly reported confirmed | 107 |
a potential target for | 107 |
on the development of | 107 |
disease caused by sars | 107 |
predictors of mortality due | 107 |
clinical characteristics and outcomes | 107 |
cell entry and receptor | 107 |
aim of this study | 107 |
incubation period of coronavirus | 107 |
in viral shedding and | 107 |
inactive inactive inactive inactive | 107 |
from person to person | 107 |
to note that the | 107 |
period of coronavirus disease | 107 |
results showed that the | 107 |
at least one of | 106 |
to be related to | 106 |
dynamics in viral shedding | 106 |
at the active site | 106 |
to an increase in | 106 |
of probable sars cases | 106 |
complete genome sequence of | 106 |
named severe acute respiratory | 106 |
of hydroxychloroquine and azithromycin | 106 |
infected vero e cells | 106 |
gastrointestinal infection of sars | 106 |
for a long time | 106 |
this study was supported | 106 |
neutralizing antibodies against sars | 106 |
a significant number of | 106 |
temporal dynamics in viral | 106 |
viral rna in the | 106 |
in chinese horseshoe bats | 106 |
and transmissibility of covid | 106 |
in relation to covid | 106 |
patients diagnosed with covid | 106 |
an outbreak of severe | 106 |
the respiratory tract of | 106 |
loss of smell and | 106 |
of igm and igg | 106 |
and it has been | 106 |
in the lungs and | 106 |
and the united states | 106 |
the identification of the | 106 |
of receptor recognition by | 106 |
of acute lung injury | 106 |
the entry of sars | 106 |
lower respiratory tract infection | 106 |
initial virological and clinical | 106 |
in patients with cancer | 105 |
role of lopinavir ritonavir | 105 |
an overview of their | 105 |
basis of receptor recognition | 105 |
outbreak of coronavirus disease | 105 |
the respiratory failure of | 105 |
of their replication and | 105 |
on the same day | 105 |
in patients with a | 105 |
sars coronavirus infection and | 105 |
sars in hong kong | 105 |
and angiotensin receptor blockers | 105 |
receptor recognition by sars | 105 |
entry into target cells | 105 |
than that of sars | 105 |
pathogenic coronavirus isolated from | 105 |
to the general population | 105 |
with regard to the | 105 |
added to each well | 105 |
respiratory failure of covid | 105 |
had no role in | 105 |
as a positive control | 105 |
in mice transgenic for | 105 |
overview of their replication | 105 |
natural science foundation of | 105 |
the rbd of sars | 105 |
virological and clinical findings | 105 |
molecular and serological investigation | 105 |
and serological investigation of | 105 |
structural basis of receptor | 105 |
we did not observe | 105 |
of traditional chinese medicine | 105 |
stage of the disease | 104 |
viral shedding and transmissibility | 104 |
article can be found | 104 |
implication of multiple shedding | 104 |
a pandemic by the | 104 |
as the cause of | 104 |
test was used to | 104 |
in children and adolescents | 104 |
authors read and approved | 104 |
and the possibility of | 104 |
airway epithelial cells and | 104 |
is associated with increased | 104 |
of type i interferon | 104 |
was carried out using | 104 |
of patients in the | 104 |
of multiple shedding routes | 104 |
phase of the disease | 104 |
morbidity and mortality in | 104 |
are highly expressed in | 104 |
evolution of coronavirus spike | 104 |
shedding and transmissibility of | 104 |
studies have demonstrated that | 104 |
of patients admitted to | 104 |
and treatment of novel | 103 |
in one of the | 103 |
are natural reservoirs of | 103 |
appears to be a | 103 |
angiotensin i to angiotensin | 103 |
update on the status | 103 |
was estimated to be | 103 |
influenza a and b | 103 |
based dashboard to track | 103 |
of transmission of sars | 103 |
dashboard to track covid | 103 |
with the severe acute | 103 |
media briefing on covid | 103 |
new insights into the | 103 |
of the host cell | 103 |
due to the fact | 103 |
the effects of the | 103 |
of its spike protein | 103 |
plays a key role | 103 |
in the emergency department | 103 |
feline infectious peritonitis virus | 103 |
in the time of | 103 |
receptor binding domain of | 103 |
significant difference in the | 102 |
of the virus is | 102 |
clinical course of patients | 102 |
their replication and pathogenesis | 102 |
patients who did not | 102 |
a cohort of patients | 102 |
clinical features and short | 102 |
the binding free energy | 102 |
outbreak in hong kong | 102 |
bats are natural reservoirs | 102 |
in vitro activity against | 102 |
on the epithelial cells | 102 |
the epidemic and the | 102 |
fatal severe acute respiratory | 102 |
in patients of novel | 102 |
patients with hypertension and | 102 |
the main protease of | 102 |
a short period of | 102 |
in this study was | 102 |
for at least days | 102 |
patients of novel coronavirus | 102 |
on the origin and | 102 |
study clinical features of | 102 |
results suggest that the | 102 |
are at increased risk | 102 |
novel coronavirus outbreak in | 102 |
have been detected in | 102 |
into the host cells | 102 |
and evolution of coronavirus | 101 |
sars in the greater | 101 |
the novel severe acute | 101 |
in the midst of | 101 |
spike glycoprotein of the | 101 |
symptoms such as fever | 101 |
viral load of sars | 101 |
observed in patients with | 101 |
identification and characterization of | 101 |
evolution of the novel | 101 |
active site of the | 101 |
is closely related to | 101 |
term outcomes of patients | 101 |
is related to the | 101 |
patients with suspected or | 101 |
cells in patients with | 101 |
have been identified in | 101 |
descriptive study clinical characteristics | 101 |
more than half of | 101 |
role in the pathogenesis | 101 |
of chest ct and | 101 |
from sars to mers | 100 |
at higher risk for | 100 |
treatment of middle east | 100 |
of interest the authors | 100 |
the european society of | 100 |
chest ct and rt | 100 |
despite the fact that | 100 |
natural reservoirs of sars | 100 |
herpes simplex virus type | 100 |
reproduction in any medium | 100 |
number of patients with | 100 |
severe acute respiratory infections | 100 |
correlation of chest ct | 100 |
use of remdesivir for | 100 |
outbreak of sars in | 100 |
of deceased patients with | 100 |
patients with lung cancer | 100 |
of the present study | 100 |
this article can be | 100 |
and reproduction in any | 100 |
key role in the | 100 |
from sars and mers | 100 |
expression of the sars | 100 |
potential conflicts of interest | 100 |
adult respiratory distress syndrome | 100 |
be associated with the | 100 |
in up to of | 100 |
binding domain of sars | 100 |
with onset of illness | 99 |
pneumonia of unknown etiology | 99 |
the gold standard for | 99 |
the adaptive immune response | 99 |
the cumulative number of | 99 |
the sequence of the | 99 |
systematic reviews and meta | 99 |
infection in patients with | 99 |
the lack of a | 99 |
cells infected with sars | 99 |
a h n virus | 99 |
play a crucial role | 99 |
in order to prevent | 99 |
increased risk for covid | 99 |
are more susceptible to | 99 |
in patients with chronic | 99 |
national natural science foundation | 99 |
case fatality rate of | 99 |
in the central nervous | 99 |
interest the authors declare | 99 |
science foundation of china | 99 |
cell responses to sars | 98 |
the efficacy of the | 98 |
hypertension and diabetes mellitus | 98 |
might be due to | 98 |
is similar to that | 98 |
and respiratory syncytial virus | 98 |
expression of ace receptor | 98 |
is highly expressed in | 98 |
all authors read and | 98 |
those who did not | 98 |
figure a and b | 98 |
provides a basis for | 98 |
human bronchial epithelial cells | 98 |
of chloroquine and hydroxychloroquine | 98 |
and cd t cell | 98 |
onset of illness from | 98 |
was reported to be | 98 |
is a member of | 98 |
reported in the literature | 98 |
a potential conflict of | 98 |
discovery and therapeutic options | 98 |
the virus to the | 98 |
respiratory tract infections in | 98 |
is estimated to be | 98 |
the number of deaths | 98 |
a median of days | 98 |
the spike protein and | 98 |
distribution of severe acute | 98 |
closely related to the | 97 |
research is needed to | 97 |
expression profiling of ace | 97 |
the genome of sars | 97 |
be construed as a | 97 |
more than of the | 97 |
the novel coronavirus pneumonia | 97 |
was performed on the | 97 |
admitted to the intensive | 97 |
the course of covid | 97 |
of vero e cells | 97 |
we also found that | 97 |
research was conducted in | 97 |
is similar to the | 97 |
the clinical features of | 97 |
the number of people | 97 |
of the coronavirus study | 97 |
remdesivir for the treatment | 97 |
with the presence of | 97 |
as part of a | 97 |
acute respiratory syndrome clinical | 97 |
the amino acid sequence | 97 |
acute respiratory syndrome sars | 97 |
for the purpose of | 97 |
therapeutic efficacy of remdesivir | 97 |
could be construed as | 97 |
in adults with severe | 97 |
in a group of | 97 |
the detection of the | 97 |
inhibits the replication of | 97 |
was the most common | 97 |
treatment of critically ill | 97 |
of health care workers | 96 |
commercial or financial relationships | 96 |
detection of sars coronavirus | 96 |
of cases of severe | 96 |
the republic of korea | 96 |
and cellular immune responses | 96 |
in wuhan clinical characteristics | 96 |
potent inhibitor of sars | 96 |
cases with onset of | 96 |
to be effective against | 96 |
is essential for the | 96 |
or financial relationships that | 96 |
remdesivir for patients with | 96 |
severity of coronavirus disease | 96 |
which this version posted | 96 |
fusion of the viral | 96 |
presence of the virus | 96 |
in a number of | 96 |
acute lung injury in | 96 |
in severe coronavirus disease | 96 |
conflict of interest the | 96 |
contamination by severe acute | 96 |
the s s site | 96 |
financial relationships that could | 96 |
of the risk of | 96 |
the coronavirus spike protein | 96 |
respiratory syndrome a novel | 96 |
converting enzyme protects from | 96 |
risk of severe covid | 96 |
the etiological agent of | 95 |
impact of the covid | 95 |
patients infected with covid | 95 |
it remains to be | 95 |
syndrome a novel coronavirus | 95 |
pathogenesis of coronavirus disease | 95 |
probable sars cases with | 95 |
syndrome severe acute respiratory | 95 |
for the production of | 95 |
that could be construed | 95 |
clinical characteristics of deceased | 95 |
cytokines such as il | 95 |
incubated for h at | 95 |
an outbreak of pneumonia | 95 |
characteristics of deceased patients | 95 |
in this study we | 95 |
was considered statistically significant | 95 |
can be used in | 95 |
other lineage b betacoronaviruses | 95 |
study of patients with | 95 |
it has been proposed | 95 |
of remdesivir for patients | 95 |
with the host cell | 95 |
the presence of antibodies | 95 |
ethics committee of the | 95 |
cd t cells were | 95 |
sars cases with onset | 95 |
in health care workers | 95 |
immune responses to sars | 95 |
be attributed to the | 95 |
of t cell responses | 94 |
in the cerebrospinal fluid | 94 |
there are currently no | 94 |
and clinical therapies on | 94 |
as a potential conflict | 94 |
england journal of medicine | 94 |
with hypertension and diabetes | 94 |
all authors have declared | 94 |
used to determine the | 94 |
as the gene source | 94 |
the national institutes of | 94 |
the virus has been | 94 |
to be effective in | 94 |
in a series of | 94 |
o o f journal | 94 |
pathogenesis of severe acute | 94 |
is the most common | 94 |
any commercial or financial | 94 |
the research was conducted | 94 |
tested positive for covid | 94 |
effective in inhibiting sars | 94 |
a human monoclonal antibody | 94 |
antibodies in patients with | 94 |
and severity of covid | 94 |
the gene source of | 94 |
construed as a potential | 94 |
from a symptomatic patient | 94 |
a broad spectrum of | 94 |
epidemiology and pathogenesis of | 94 |
the angiotensin converting enzyme | 94 |
relationships that could be | 94 |
of the general population | 94 |
o f journal pre | 94 |
are considered to be | 94 |
has yet to be | 94 |
of any commercial or | 94 |
wuhan clinical characteristics of | 94 |
summary of probable sars | 94 |
that the presence of | 94 |
absence of any commercial | 94 |
deceased patients with coronavirus | 94 |
there is no specific | 94 |
a significant reduction in | 93 |
it was observed that | 93 |
with novel coronavirus disease | 93 |
assay for the detection | 93 |
as a receptor for | 93 |
proteins of severe acute | 93 |
for h at room | 93 |
admitted to hospital with | 93 |
acute kidney injury in | 93 |
and other lineage b | 93 |
as described in the | 93 |
new england journal of | 93 |
therapies on coronavirus disease | 93 |
available under a perpetuity | 93 |
version of the manuscript | 93 |
antiviral activity against sars | 93 |
the number of covid | 93 |
a vital role in | 93 |
the rbd of the | 93 |
of antibodies against sars | 93 |
of pediatric patients with | 93 |
in close proximity to | 93 |
receptor usage for sars | 93 |
in the lung and | 93 |
in response to sars | 93 |
solid organ transplant recipients | 93 |
clinical therapies on coronavirus | 93 |
onset of symptoms and | 93 |
the integrity of the | 93 |
our results indicate that | 93 |
has been described in | 93 |
a high rate of | 93 |
combination of hydroxychloroquine and | 93 |
is part of the | 93 |
the control of the | 93 |
the management of the | 93 |
that the research was | 93 |
the second week of | 93 |
efficacy of remdesivir and | 93 |
disease is associated with | 93 |
associated with decreased mortality | 93 |
olfactory and gustatory dysfunctions | 92 |
pcr testing in coronavirus | 92 |
respiratory syndrome coronavirus receptor | 92 |
the formation of a | 92 |
study has several limitations | 92 |
testing in coronavirus disease | 92 |
of novel coronavirus infections | 92 |
severe acute lung failure | 92 |
the crystal structures of | 92 |
in acute lung injury | 92 |
have been described in | 92 |
with decreased mortality in | 92 |
and the need for | 92 |
coronaviruses as the gene | 92 |
conducted in the absence | 92 |
transmission and clinical therapies | 92 |
drug discovery and therapeutic | 92 |
in the host cell | 92 |
by the national health | 92 |
at the early stage | 92 |
respiratory syndrome severe acute | 92 |
in an effort to | 92 |
exposure to the virus | 92 |
of t cells in | 92 |
and moderate coronavirus disease | 92 |
severe and moderate coronavirus | 92 |
a basis for design | 92 |
higher in patients with | 92 |
for the control of | 92 |
no significant difference between | 92 |
admitted to intensive care | 92 |
are known to be | 92 |
in the s subunit | 92 |
and pathogenesis of coronavirus | 92 |
and disease severity in | 91 |
is expected to be | 91 |
the host immune system | 91 |
a large proportion of | 91 |
one of the following | 91 |
to the risk of | 91 |
of the severity of | 91 |
been reported in the | 91 |
of morbidity and mortality | 91 |
previous studies have shown | 91 |
and interferon beta against | 91 |
plays a role in | 91 |
equipment contamination by severe | 91 |
the average number of | 91 |
comparative therapeutic efficacy of | 91 |
in the sera of | 91 |
main protease provides a | 91 |
the epidemiology and pathogenesis | 91 |
the course of infection | 91 |
rna was extracted from | 91 |
in critically ill covid | 91 |
we did not find | 91 |
the molecular biology of | 91 |
been identified as a | 91 |
in this study are | 91 |
personal protective equipment contamination | 91 |
in the lower respiratory | 91 |
treatment is associated with | 91 |
a nonhuman primate model | 91 |
remdesivir and combination lopinavir | 91 |
for design of improved | 91 |
the median age was | 91 |
a group of patients | 91 |
interferon beta against mers | 91 |
and discovery of its | 91 |
of remdesivir and combination | 91 |
low molecular weight heparin | 91 |
viral replication in the | 91 |
even in the absence | 91 |
discovery of its inhibitors | 90 |
and potential therapeutic target | 90 |
was found in the | 90 |
highly expressed in nasal | 90 |
have been observed in | 90 |
the detection of viral | 90 |
coronaviridae study group of | 90 |
we were unable to | 90 |
did not receive any | 90 |
the s domain of | 90 |
divergence of the novel | 90 |
clinical and epidemiological features | 90 |
as a negative control | 90 |
the distribution of the | 90 |
can also be used | 90 |
was based on the | 90 |
less toxic derivative of | 90 |
has been demonstrated to | 90 |
pathogenic human coronavirus infections | 90 |
was identified as a | 90 |
a link to the | 90 |
the treatment of the | 90 |
the emergence of the | 90 |
care of patients with | 90 |
protective equipment contamination by | 90 |
patients with severe sars | 90 |
was not detected in | 90 |
protease provides a basis | 90 |
in order to identify | 90 |
there was a significant | 90 |
therapeutic options for the | 90 |
toxic derivative of chloroquine | 90 |
was performed using a | 90 |
of human coronavirus oc | 90 |
during the acute phase | 90 |
of west nile virus | 90 |
characteristics of patients with | 90 |
a less toxic derivative | 90 |
and the severity of | 90 |
were detected in the | 90 |
structural and functional basis | 90 |
in a nonhuman primate | 90 |
of the active site | 90 |
of the presence of | 89 |
the online version of | 89 |
of emerging infectious diseases | 89 |
new york city area | 89 |
innate and adaptive immunity | 89 |
in china clinical characteristics | 89 |
and divergence of the | 89 |
role in the respiratory | 89 |
there was no evidence | 89 |
acute respiratory syndrome severe | 89 |
converting enzyme inhibitors and | 89 |
coronavirus disease in wuhan | 89 |
for the design of | 89 |
with increased risk of | 89 |
play a critical role | 89 |
the spread of infection | 89 |
protein interaction map reveals | 89 |
statistical analysis was performed | 89 |
proportion of patients with | 89 |
version of this article | 89 |
epidemic and the challenges | 89 |
coronavirus severe acute respiratory | 89 |
genome composition and divergence | 89 |
data suggest that the | 89 |
the findings of this | 89 |
among patients hospitalized with | 88 |
in nasal epithelial cells | 88 |
the possibility of a | 88 |
the emerging human coronavirus | 88 |
china epidemiological and clinical | 88 |
the risk of severe | 88 |
of the disease is | 88 |
a novel human coronavirus | 88 |
can be divided into | 88 |
is effective in inhibiting | 88 |
patients in hong kong | 88 |
viral rna mini kit | 88 |
to evaluate the efficacy | 88 |
it is not possible | 88 |
provided the original author | 88 |
is not included in | 88 |
is an open access | 88 |
it is well known | 88 |
creative commons attribution license | 88 |
respiratory syndrome corona virus | 88 |
authors declare that the | 88 |
enzyme inhibitors and angiotensin | 88 |
should be given to | 88 |
dipeptidyl peptidase is a | 88 |
virus in chinese horseshoe | 88 |
syndrome coronavirus envelope protein | 88 |
was one of the | 88 |
in china clinical features | 88 |
as a public health | 88 |
is in line with | 88 |
novel coronavirus from the | 88 |
which may lead to | 88 |
the binding of sars | 88 |
ace is expressed in | 88 |
had at least one | 88 |
injury in patients with | 88 |
was defined as a | 88 |
authors contributed to the | 88 |
at an early stage | 88 |
hydroxychloroquine and azithromycin in | 88 |
in the crystal structure | 87 |
to the onset of | 87 |
mechanisms and potential therapeutic | 87 |
peptidase is a functional | 87 |
in order to reduce | 87 |
a pandemic on march | 87 |
we are grateful to | 87 |
molecular mechanisms and potential | 87 |
h n influenza a | 87 |
patients admitted to hospital | 87 |
by the institutional review | 87 |
respiratory syndrome coronavirus envelope | 87 |
it has been observed | 87 |
encephalitis associated with sars | 87 |
for the emerging human | 87 |
receptor for the emerging | 87 |
cells of oral mucosa | 87 |
the patients in the | 87 |
findings of this study | 87 |
acute respiratory infection when | 87 |
highly expressed in the | 87 |
sars coronavirus infection in | 87 |
the virus that causes | 87 |
may increase the risk | 87 |
in this article are | 87 |
in intensive care unit | 87 |
could be detected in | 87 |
case series of patients | 87 |
of fatal severe acute | 87 |
who have recovered from | 87 |
to the formation of | 87 |
decreased mortality in severe | 87 |
epithelial cells of oral | 87 |
and specificity of the | 87 |
coronavirus in wuhan clinical | 87 |
is associated with severe | 87 |
from human to human | 87 |
and control of the | 87 |
has been used for | 86 |
were excluded from the | 86 |
has been proposed as | 86 |
of the epidemic in | 86 |
cells were treated with | 86 |
mortality in severe coronavirus | 86 |
in order to determine | 86 |
prince of wales hospital | 86 |
inhibitor of sars coronavirus | 86 |
to participate in the | 86 |
duration of viral shedding | 86 |
from symptom onset to | 86 |
it can be seen | 86 |
evidence does not support | 86 |
anticoagulant treatment is associated | 86 |
also found to be | 86 |
cov infection in a | 86 |
with the aim of | 86 |
of cytokine storm and | 86 |
will be important to | 86 |
during the first week | 86 |
on the th day | 86 |
other parts of the | 86 |
first case of meningitis | 86 |
effective treatment of severe | 86 |
the possible role of | 86 |
the function of the | 86 |
the human ace receptor | 86 |
us food and drug | 86 |
lung pathology of fatal | 86 |
of allergy and infectious | 86 |
to the severe acute | 86 |
from severe acute lung | 86 |
the past two decades | 86 |
none of the patients | 86 |
the median time from | 86 |
in the same way | 86 |
the large number of | 86 |
was first identified in | 86 |
pathology of fatal severe | 86 |
inhibitors and angiotensin receptor | 86 |
of smell or taste | 86 |
and functional basis of | 85 |
sars coronavirus spike glycoprotein | 85 |
on the host cell | 85 |
in health care settings | 85 |
with a total of | 85 |
from the united states | 85 |
an increasing number of | 85 |
and indicate if changes | 85 |
were the most common | 85 |
are responsible for the | 85 |
could be used for | 85 |
infections in engineered human | 85 |
in comparison to the | 85 |
like virus in chinese | 85 |
the primary cause of | 85 |
infected with the novel | 85 |
been shown to inhibit | 85 |
is not possible to | 85 |
appropriate credit to the | 85 |
syndrome coronavirus infection in | 85 |
is a lack of | 85 |
provide a link to | 85 |
in patients treated with | 85 |
has been suggested to | 85 |
of ebola virus disease | 85 |
the magnitude of the | 85 |
taking into account the | 85 |
are available from the | 85 |
infectious disease caused by | 85 |
online version of this | 85 |
risk factor for covid | 85 |
according to the who | 85 |
uses the ace receptor | 85 |
has been used in | 85 |
protects from severe acute | 85 |
limit of detection of | 85 |
during the period of | 85 |
patients were treated with | 85 |
is defined as the | 85 |
most of the patients | 85 |
if changes were made | 85 |
patients recovered from covid | 85 |
minimize the risk of | 85 |
in the respiratory failure | 85 |
the length of the | 85 |
to be infected with | 85 |
of ace receptor of | 85 |
in the transmission of | 85 |
cd t cells and | 85 |
clinical evidence does not | 85 |
reduce the number of | 85 |
have a role in | 85 |
indicate if changes were | 85 |
give appropriate credit to | 85 |
in engineered human tissues | 85 |
be detected in the | 85 |
the risk of death | 85 |
of neonates born to | 84 |
risk of human transmission | 84 |
performed according to the | 84 |
the american college of | 84 |
declare that the research | 84 |
is well known that | 84 |
at a higher risk | 84 |
novel coronavirus pneumonia emergency | 84 |
is located in the | 84 |
with a focus on | 84 |
evolution of the sars | 84 |
has been found in | 84 |
associated with increased risk | 84 |
from the onset of | 84 |
china a pneumonia outbreak | 84 |
its spike protein for | 84 |
the s protein and | 84 |
the present study was | 84 |
and is associated with | 84 |
pneumonia in china a | 84 |
a pivotal role in | 84 |
treatment of coronavirus disease | 84 |
engineered human tissues using | 84 |
of nosocomial transmission of | 84 |
coronavirus disease patients with | 84 |
innate immune response to | 84 |
main protease of sars | 84 |
manifestations in patients with | 84 |
patients with severe respiratory | 84 |
syndrome identification of a | 84 |
in the acute phase | 84 |
enzyme protects from severe | 84 |
activates the nlrp inflammasome | 84 |
ministry of health and | 84 |
van doremalen et al | 84 |
from the corresponding author | 84 |
respiratory syndrome coronavirus nsp | 84 |
in the design of | 84 |
ongoing wuhan outbreak and | 84 |
igg and igm antibodies | 84 |
be noted that the | 83 |
from the ongoing wuhan | 83 |
outbreak and modeling of | 83 |
spike protein for risk | 83 |
has not been reported | 83 |
coronavirus pneumonia emergency response | 83 |
a median age of | 83 |
was also observed in | 83 |
n and h n | 83 |
the national natural science | 83 |
influenza a virus infection | 83 |
the ongoing wuhan outbreak | 83 |
severe coronavirus disease patients | 83 |
in the detection of | 83 |
wuhan outbreak and modeling | 83 |
a decrease in the | 83 |
high morbidity and mortality | 83 |
well as in the | 83 |
pneumonia emergency response epidemiology | 83 |
preferred reporting items for | 83 |
a significant proportion of | 83 |
first cases of covid | 83 |
coronavirus open reading frame | 83 |
for rapid detection of | 83 |
compared to that of | 83 |
the involvement of the | 83 |
the s s cleavage | 83 |
characterization of severe acute | 83 |
disease patients with coagulopathy | 83 |
coronavirus from the ongoing | 83 |
protein for risk of | 83 |
response to viral infection | 83 |
modeling of its spike | 83 |
mortality in hospitalized patients | 83 |
for risk of human | 83 |
department of health and | 83 |
clinical features of the | 83 |
for the analysis of | 83 |
and modeling of its | 83 |
there is a lack | 83 |
were used for the | 83 |
the dynamics of the | 83 |
plays a critical role | 83 |
meningitis encephalitis associated with | 83 |
the effectiveness of the | 82 |
of airborne transmission of | 82 |
of a bat sars | 82 |
and control of covid | 82 |
the human respiratory tract | 82 |
as well as their | 82 |
were performed using the | 82 |
that there was no | 82 |
is a risk factor | 82 |
a global health emergency | 82 |
emergence of a novel | 82 |
avian infectious bronchitis virus | 82 |
h n and h | 82 |
increasing the risk of | 82 |
does not support corticosteroid | 82 |
support corticosteroid treatment for | 82 |
reduce the spread of | 82 |
for design of anti | 82 |
functional basis of sars | 82 |
should be taken into | 82 |
national institute of allergy | 82 |
dexamethasone in hospitalized patients | 82 |
grade soluble human ace | 82 |
characteristics of pediatric sars | 82 |
institute of allergy and | 82 |
personal protective equipment for | 82 |
features and clinical course | 82 |
spike protein is a | 82 |
chloroquine is a potent | 82 |
the understanding of the | 82 |
t cell responses in | 82 |
we believe that the | 82 |
case of meningitis encephalitis | 82 |
least one of the | 82 |
study of hydroxychloroquine in | 82 |
disease severity in patients | 82 |
can be considered as | 82 |
the accuracy of the | 82 |
the food and drug | 82 |
of meningitis encephalitis associated | 82 |
infected with the virus | 82 |
the relationship between the | 82 |
therapy in patients with | 82 |
not support corticosteroid treatment | 82 |
entry by using human | 82 |
respiratory syndrome coronavirus entry | 82 |
tumor necrosis factor alpha | 82 |
of the use of | 82 |
to the spread of | 81 |
results of this study | 81 |
there were no significant | 81 |
at high risk for | 81 |
agent of severe acute | 81 |
of patients hospitalized with | 81 |
were similar to those | 81 |
open access article distributed | 81 |
h n avian influenza | 81 |
in the cytoplasm of | 81 |
were shown to be | 81 |
a first case of | 81 |
it is crucial to | 81 |
have been identified as | 81 |
adults with severe covid | 81 |